Suprava TZ 562.5 mg Injection 1's Substitute

Suprava TZ 562.5 mg Injection 1's contains Ceftriaxone and Tazobactum. Ceftriaxone is an antibiotic that works by interfering with the formation of the bacterial cell wall (a protective covering) that is necessary for their survival. Thereby damages the bacterial cell wall and kills bacteria. Tazobactum is a beta-lactamase inhibitor that enhances the activity of ceftriaxone and decreases resistance.

Suprava TZ 562.5 mg Injection 1's may interfere with urine test (for sugar) and Coomb’s test (blood test) giving false-positive results. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Suprava TZ 562.5 mg Injection 1's.

You are not recommended to take Suprava TZ 562.5 mg Injection 1's with streptomycin as co-administration of these two medicines may increase the risk of kidney damage. However, please consult your doctor before taking Suprava TZ 562.5 mg Injection 1's with other medicines to adjust the dose appropriately.

Suprava TZ 562.5 mg Injection 1's may cause diarrhoea as a common side effect. However, if the condition persists, worsens or notices blood or mucus in stools, avoid taking Suprava TZ 562.5 mg Injection 1's and consult a doctor immediately.

Suprava TZ 562.5 mg Injection 1's is not used to treat viral infections. Suprava TZ 562.5 mg Injection 1's is an antibiotic which is used to treat only bacterial infections.